CLOV

SEC source: 0001999086-25-000007 · wk-form4_1760733649.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,405,835

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001971702-25-000006 · wk-form4_1760733489.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,274,463

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000240 · wk-form4_1759869459.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,043,172

F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. These shares were sold at a price of $2.65.

SEC source: 0001801170-25-000240 · wk-form4_1759869459.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,045,184

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000239 · wk-form4_1759522212.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,165,562

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-25-000010 · wk-form4_1758312781.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,053,890

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.13, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001801170-25-000229 · wk-form4_1758056852.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,058,804

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000231 · wk-form4_1758151921.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,463,084

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000229 · wk-form4_1758056852.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,067,495

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and originally reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000227 · wk-form4_1758053947.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,573,425

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000223 · wk-form4_1755552710.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,469,487

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000221 · wk-form4_1755204262.xml · nonDerivative · entry 2

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Daughter IRA

Disclosed balance after: 29,610

F2 · ownership.nature: Held in a custodial IRA for the benefit of Reporting Person's daughter, for which the Reporting Person serves as custodian.

SEC source: 0001801170-25-000221 · wk-form4_1755204262.xml · nonDerivative · entry 1

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Son IRA

Disclosed balance after: 27,600

F1 · ownership.nature: Held in a custodial IRA for the benefit of Reporting Person's son, for which the Reporting Person serves as custodian.

SEC source: 0001801170-25-000207 · wk-form4_1754683623.xml · nonDerivative · entry 2

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,856,247

F2 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.15 to $2.21, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 2 to this Form 4.

SEC source: 0001801170-25-000219 · wk-form4_1755031617.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,474,512

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on August 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000207 · wk-form4_1754683623.xml · nonDerivative · entry 1

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,824,267

F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.16 to $2.32, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4.

SEC source: 0001801170-25-000198 · wk-form4_1754513958.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,261,485

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.86 to $2.93, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001801170-25-000188 · wk-form4_1754343063.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,268,308

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000187 · wk-form4a_1754341623.xml · nonDerivative · entry 2

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,476,946

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

F3 · balance_after: Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 31, 2025.

SEC source: 0001801170-25-000186 · wk-form4_1754340322.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,671,837

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000185 · wk-form4_1754340005.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,471,357

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000182 · wk-form4_1753994500.xml · nonDerivative · entry 1

Kuipers Peter J. · CIK 0001651691 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,132,591

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 29, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments beginning on the date that is three months after July 29, 2025, and ending on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.

SEC source: 0001801170-25-000176 · wk-form4_1753387862.xml · nonDerivative · entry 2

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust.

Disclosed balance after: 1,403,701

F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.40, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

SEC source: 0001801170-25-000176 · wk-form4_1753387862.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust.

Disclosed balance after: 1,494,898

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.37, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

SEC source: 0001801170-25-000174 · wk-form4a_1753216626.xml · nonDerivative · entry 2

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,496,438

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 18, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.

F3 · balance_after: Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 18, 2025.

SEC source: 0001801170-25-000170 · wk-form4a_1752189870.xml · nonDerivative · entry 2

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust.

Disclosed balance after: 1,613,498

F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.27, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4 · ownership.nature: Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

SEC source: 0001801170-25-000168 · wk-form4_1752009297.xml · nonDerivative · entry 3

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,297,821

F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.81 to $2.88, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001801170-25-000168 · wk-form4_1752009297.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,299,833

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on July 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000168 · wk-form4_1752009297.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,308,539

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001801170-25-000166 · wk-form4_1751574092.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,560,047

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on July 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000165 · wk-form4_1751489245.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,328,328

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above.

SEC source: 0001801170-25-000165 · wk-form4_1751489245.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,413,924

F1 · shares: Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. The final one-third of the number of earned restricted stock units vested and were settled on June 30, 2025.

SEC source: 0001839066-25-000008 · wk-form4a_1758056455.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,887,905

F1 · shares: This Form 4/A is being filed to solely to correct that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below.

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 1/3 of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025.

F3 · balance_after: Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2025.

SEC source: 0001801170-25-000162 · wk-form4_1750281969.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,196,401

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.92, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001801170-25-000160 · wk-form4_1750195770.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,256,032

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000158 · wk-form4_1750192547.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,216,851

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000159 · wk-form4_1750195559.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,138,535

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000158 · wk-form4_1750192547.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,225,542

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000145 · wk-form4_1747858204.xml · nonDerivative · entry 1

Kuipers Peter J. · CIK 0001651691 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,349,973

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of May 19, 2025, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of May 19, 2025, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000143 · wk-form4_1747340090.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,262,436

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000135 · wk-form4_1747081892.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,868,997

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000116 · wk-form4_1746218239.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,267,781

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000113 · wk-form4_1746217990.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,238,109

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000114 · wk-form4_1746218055.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,236,946

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000112 · wk-form4_1746217938.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,354,810

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000109 · wk-form4_1746132338.xml · nonDerivative · entry 1

Kuipers Peter J. · CIK 0001651691 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,023,326

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 29, 2025, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2025. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after April 29, 2025, and ending on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.

SEC source: 0001801170-25-000085 · wk-form4_1745354091.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,379,890

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 18, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000079 · wk-form4_1744058416.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,263,768

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000077 · wk-form4_1743712443.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,954,532

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-25-000074 · wk-form4_1742331497.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,295,074

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.